(reversible&#32

2 trials

Sponsors

Shanghai Chest Hospital, Beijing Chest Hospital, Capital Medical University

Conditions

non-small cell lung cancer (NSCLC), colorectal cancer (CRC)non-small cell lung cancer (NSCLC), colorectal cancer (CRC) , gastrointestinal stromal tumor (GIST)

Early Phase 1

The combination human 13 gene mutation Detection kit (reversible terminal termination sequencing) complements the clinical trial

Active, not recruitingChiCTR2000036422

Shanghai Chest Hospitalnon-small cell lung cancer (NSCLC), colorectal cancer (CRC) , gastrointestinal stromal tumor (GIST)

Start: 2020-09-01Updated: 2020-09-14

Unknown Phase

Clinical trials verifying the consistency of AmoyDx Essential NGS Panel (Reversible Terminator Sequencing) with local tests

RecruitingChiCTR2000039738

Beijing Chest Hospital, Capital Medical Universitynon-small cell lung cancer (NSCLC), colorectal cancer (CRC)

Start: 2020-12-20Updated: 2021-02-16